Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Therapeutics Insight with Inclusive Immunopharmacology Explication of Human Rotavirus A for the Treatment of Diarrhea.

Hossain MU, Hashem A, Keya CA, Salimullah M.

Front Pharmacol. 2016 Jun 23;7:153. doi: 10.3389/fphar.2016.00153. eCollection 2016.

2.

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

Mizoguti Dde F, Hungria EM, Freitas AA, Oliveira RM, Cardoso LP, Costa MB, Sousa AL, Duthie MS, Stefani MM.

Mem Inst Oswaldo Cruz. 2015 Nov;110(7):914-20. doi: 10.1590/0074-02760150198.

3.

IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy.

Hagge DA, Scollard DM, Ray NA, Marks VT, Deming AT, Spencer JS, Adams LB.

PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3149. doi: 10.1371/journal.pntd.0003149. eCollection 2014 Sep.

4.

Phage display and synthetic peptides as promising biotechnological tools for the serological diagnosis of leprosy.

Alban SM, de Moura JF, Thomaz-Soccol V, Bührer Sékula S, Alvarenga LM, Mira MT, Olortegui CC, Minozzo JC.

PLoS One. 2014 Aug 29;9(8):e106222. doi: 10.1371/journal.pone.0106222. eCollection 2014.

5.

Analysis of antigens of Mycobacterium leprae by interaction to sera IgG, IgM, and IgA response to improve diagnosis of leprosy.

Kumar A, Parkash O, Girdhar BK.

Biomed Res Int. 2014;2014:283278. doi: 10.1155/2014/283278. Epub 2014 Jun 29. Review.

6.

Gene expression profile and immunological evaluation of unique hypothetical unknown proteins of Mycobacterium leprae by using quantitative real-time PCR.

Kim HJ, Prithiviraj K, Groathouse N, Brennan PJ, Spencer JS.

Clin Vaccine Immunol. 2013 Feb;20(2):181-90. doi: 10.1128/CVI.00419-12. Epub 2012 Dec 12.

7.

Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.

Martins MV, Guimarães MM, Spencer JS, Hacker MA, Costa LS, Carvalho FM, Geluk A, van der Ploeg-van Schip JJ, Pontes MA, Gonçalves HS, de Morais JP, Bandeira TJ, Pessolani MC, Brennan PJ, Pereira GM.

PLoS Negl Trop Dis. 2012;6(4):e1616. doi: 10.1371/journal.pntd.0001616. Epub 2012 Apr 24.

8.

New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.

Geluk A, Bobosha K, van der Ploeg-van Schip JJ, Spencer JS, Banu S, Martins MV, Cho SN, Franken KL, Kim HJ, Bekele Y, Uddin MK, Hadi SA, Aseffa A, Pessolani MC, Pereira GM, Dockrell HM, Ottenhoff TH.

J Immunol. 2012 May 15;188(10):4782-91. doi: 10.4049/jimmunol.1103452. Epub 2012 Apr 13.

9.

Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls.

Bobosha K, van der Ploeg-van Schip JJ, Esquenazi DA, Guimarães MM, Martins MV, Bekele Y, Fantahun Y, Aseffa A, Franken KL, Gismondi RC, Pessolani MC, Ottenhoff TH, Pereira GM, Geluk A.

J Trop Med. 2012;2012:132049. doi: 10.1155/2012/132049. Epub 2012 Jan 29.

10.

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.

Checkley AM, Wyllie DH, Scriba TJ, Golubchik T, Hill AV, Hanekom WA, McShane H.

PLoS One. 2011;6(10):e26434. doi: 10.1371/journal.pone.0026434. Epub 2011 Oct 25.

11.

The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.

Fischer EA, de Vlas SJ, Habbema JD, Richardus JH.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1330. doi: 10.1371/journal.pntd.0001330. Epub 2011 Sep 20.

12.

ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria.

Geluk A, van den Eeden SJ, Dijkman K, Wilson L, Kim HJ, Franken KL, Spencer JS, Pessolani MC, Pereira GM, Ottenhoff TH.

J Immunol. 2011 Aug 1;187(3):1393-402. doi: 10.4049/jimmunol.1100980. Epub 2011 Jun 24.

13.

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.

Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, Duthie MS.

BMC Infect Dis. 2011 Jan 26;11:26. doi: 10.1186/1471-2334-11-26.

14.

Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

Spencer JS, Kim HJ, Wheat WH, Chatterjee D, Balagon MV, Cellona RV, Tan EV, Gelber R, Saunderson P, Duthie MS, Reece ST, Burman W, Belknap R, Mac Kenzie WR, Geluk A, Oskam L, Dockrell HM, Brennan PJ; IDEAL Consortium.

Clin Vaccine Immunol. 2011 Feb;18(2):260-7. doi: 10.1128/CVI.00472-10. Epub 2010 Dec 22.

15.

Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Singh P, Cole ST.

Future Microbiol. 2011 Jan;6(1):57-71. doi: 10.2217/fmb.10.153. Review.

16.

Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.

Geluk A, van der Ploeg-van Schip JJ, van Meijgaarden KE, Commandeur S, Drijfhout JW, Benckhuijsen WE, Franken KL, Naafs B, Ottenhoff TH.

Clin Vaccine Immunol. 2010 Jun;17(6):993-1004. doi: 10.1128/CVI.00046-10. Epub 2010 Apr 28.

Supplemental Content

Support Center